Skip to main content
. Author manuscript; available in PMC: 2007 May 24.
Published in final edited form as: J Pharmacol Exp Ther. 2006 Jul 25;319(2):523–532. doi: 10.1124/jpet.106.109215

Figure 4. Variability of fetal CYP2J2 immunoreactive protein and relationship between protein content and mRNA expression.

Figure 4

Each lane contained 4 μg microsomal protein. Anti-CYP2J2 antibody was used for panels A and B.

Immunoblot with representative samples demonstrating the range of immunoreactive protein observed. For descriptive purposes, ‘low’, ‘intermediate’ and ‘high’ protein categories were assigned by visual inspection. There was no relationship between genotype and amount of protein observed.